Torhild Garen
- Coordinateur, NOSVAR
- +47 23 07 39 01
Publications 2021
Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic Sclerosis
Arthritis Rheumatol., 73 (7), 1277-1287
DOI 10.1002/art.41665
Publications 2020
Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
PLoS One, 15 (5), e0232739
DOI 10.1371/journal.pone.0232739
Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort
RHEUMATOLOGY, 59 (10), 2920-2929
DOI 10.1093/rheumatology/keaa026
Patients with non-Sjogren's sicca report poorer general and oral health-related quality of life than patients with Sjogren's syndrome: a cross-sectional study
Sci Rep, 10 (1), 2063
DOI 10.1038/s41598-020-59078-0
Publications 2019
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
Ann. Rheum. Dis., 78 (7), 979-987
DOI 10.1136/annrheumdis-2018-214816
Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
Arthritis Rheumatol., 71 (6), 972-982
DOI 10.1002/art.40815
Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides
RHEUMATOLOGY, 58 (2), 313-320
DOI 10.1093/rheumatology/key285
Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort
Am. J. Respir. Crit. Care Med., 200 (10), 1258-1266
DOI 10.1164/rccm.201903-0486OC
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis
Arthritis Rheumatol., 71 (9), 1553-1570
DOI 10.1002/art.40906
Publications 2018
Frequencies of borderline pulmonary hypertension before and after the DETECT algorithm: results from a prospective systemic sclerosis cohort
RHEUMATOLOGY, 57 (3), 480-487
DOI 10.1093/rheumatology/kex435
CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis
Arthritis Rheumatol., 70 (10), 1644-1653
DOI 10.1002/art.40534
Augmented concentrations of CX(3)CL1 are associated with interstitial lung disease in systemic sclerosis
PLoS One, 13 (11), e0206545
DOI 10.1371/journal.pone.0206545
Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis
J. Am. Coll. Cardiol., 72 (15), 1804-1813
DOI 10.1016/j.jacc.2018.07.068
Publications 2017
Comparative analyses of muscle MRI and muscular function in anti-synthetase syndrome patients and matched controls: a cross-sectional study
Arthritis Res. Ther., 19, 17
DOI 10.1186/s13075-017-1219-y
Prevalence, Incidence, and Disease Characteristics of Takayasu Arteritis by Ethnic Background: Data From a Large, Population-Based Cohort Resident in Southern Norway
Arthritis Care Res., 69 (2), 278-285
DOI 10.1002/acr.22931
Takayasu Arteritis and Pregnancy: A Population-Based Study on Outcomes and Mother/Child-Related Concerns
Arthritis Care Res., 69 (9), 1384-1390
DOI 10.1002/acr.23146
Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient Cohort
J. Rheumatol., 44 (4), 459-465
DOI 10.3899/jrheum.160867
Publications 2016
Pulmonary Involvement in the Antisynthetase Syndrome: A Comparative Cross-sectional Study
J. Rheumatol., 43 (6), 1107-1113
DOI 10.3899/jrheum.151067
Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease
RHEUMATOLOGY, 55 (1), 103-108
DOI 10.1093/rheumatology/kev300
High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis
Chest, 150 (2), 299-306
DOI 10.1016/j.chest.2016.03.004
Endostatin is higher and associated with pulmonary involvement in primary Sjogren's syndrome
Clin. Exp. Rheumatol., 34 (4), 690-693
Publications 2015
Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease
RHEUMATOLOGY, 54 (8), 1420-1428
DOI 10.1093/rheumatology/kev004
Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort
Ann. Rheum. Dis., 74 (8), 1551-1556
DOI 10.1136/annrheumdis-2013-205127
High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study
Eur. J. Neurol., 22 (4), 672-E41
DOI 10.1111/ene.12627
Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort
Semin. Arthritis Rheum., 45 (3), 301-308
DOI 10.1016/j.semarthrit.2015.06.005
The HLA profiles of mixed connective tissue disease differ distinctly from the profiles of clinically related connective tissue diseases
RHEUMATOLOGY, 54 (3), 528-535
DOI 10.1093/rheumatology/keu310
Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in Large, Well-defined Cohorts of SSc and Mixed Connective Tissue Disease
J. Rheumatol., 42 (1), 60-63
DOI 10.3899/jrheum.140047
Predictive Value of Serial High-Resolution Computed Tomography Analyses and Concurrent Lung Function Tests in Systemic Sclerosis
Arthritis Rheumatol., 67 (8), 2205-2212
DOI 10.1002/art.39166
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study
Microvasc. Res., 102, 19-24
DOI 10.1016/j.mvr.2015.07.007
Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study
Arthritis Res. Ther., 17, 231
DOI 10.1186/s13075-015-0756-5
Publications 2014
Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era
BMC Musculoskelet. Disord., 15, 289
DOI 10.1186/1471-2474-15-289
Publications 2013
Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature
RHEUMATOLOGY, 52 (7), 1208-1213
DOI 10.1093/rheumatology/kes430
Survival and Causes of Death in an Unselected, and Complete Cohort of Norwegian Patients with Systemic Sclerosis
J. Rheumatol., 40 (7), 1127-1133
DOI 10.3899/jrheum.121390
Clinical pulmonary involvement in primary Sjogren's syndrome: prevalence, quality of life and mortality-a retrospective study based on registry data
RHEUMATOLOGY, 52 (1), 173-179
DOI 10.1093/rheumatology/kes311
Publications 2012
Prevalence of systemic sclerosis in south-east Norway
RHEUMATOLOGY, 51 (9), 1600-1605
DOI 10.1093/rheumatology/kes076
High incidence and prevalence of systemic lupus erythematosus in Norway
Lupus, 21 (12), 1362-1369
DOI 10.1177/0961203312458168
Publications 2011
Oral distress in primary Sjogren's syndrome: implications for health-related quality of life
Eur. J. Oral Sci., 119 (6), 474-480
DOI 10.1111/j.1600-0722.2011.00891.x
EFFICACY OF REHABILITATION FOR PATIENTS WITH ANKYLOSING SPONDYLITIS: COMPARISON OF A FOUR-WEEK REHABILITATION PROGRAMME IN A MEDITERRANEAN AND A NORWEGIAN SETTING
J. Rehabil. Med., 43 (6), 534-542
DOI 10.2340/16501977-0804
Publications 2009
The efficacy of rehabilitation for patients with rheumatoid arthritis: comparison between a 4-week rehabilitation programme in a warm and a cold climate
Scand. J. Rheumatol., 38 (1), PII 901897742-37
DOI 10.1080/03009740802304549